Log in to save to my catalogue

Dexamethasone Treatment in Patients With Severe COVID-19: A Propensity Score-Matched Study

Dexamethasone Treatment in Patients With Severe COVID-19: A Propensity Score-Matched Study

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3e91f0236d9e45e5b929caebbb671b56

Dexamethasone Treatment in Patients With Severe COVID-19: A Propensity Score-Matched Study

About this item

Full title

Dexamethasone Treatment in Patients With Severe COVID-19: A Propensity Score-Matched Study

Publisher

Tehran: Tehran University of Medical Sciences

Journal title

Acta medica Iranica, 2022-08, Vol.60 (7), p.413

Language

English

Formats

Publication information

Publisher

Tehran: Tehran University of Medical Sciences

More information

Scope and Contents

Contents

During the coronavirus disease-2019 (COVID-19) pandemic, which was caused by the novel coronavirus, there is an ongoing controversy about the use of corticosteroids. This study aims to investigate the association between Dexamethasone treatment and clinical outcomes in patients with severe COVID-19. In this single-center retrospective cohort study,...

Alternative Titles

Full title

Dexamethasone Treatment in Patients With Severe COVID-19: A Propensity Score-Matched Study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_3e91f0236d9e45e5b929caebbb671b56

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3e91f0236d9e45e5b929caebbb671b56

Other Identifiers

ISSN

0044-6025

E-ISSN

1735-9694

DOI

10.18502/acta.v60i7.10212

How to access this item